Cite
Metabolomic signatures associated with disease severity in multiple sclerosis.
MLA
Villoslada, Pablo, et al. “Metabolomic Signatures Associated with Disease Severity in Multiple Sclerosis.” Neurology® Neuroimmunology & Neuroinflammation, vol. 4, no. 2, Mar. 2017, pp. 1–10. EBSCOhost, https://doi.org/10.1212/NXI.0000000000000321.
APA
Villoslada, P., Alonso, C., Agirrezabal, I., Kotelnikova, E., Zubizarreta, I., Pulido-Valdeolivas, I., Saiz, A., Comabella, M., Montalban, X., Villar, L., Alvarez-Cermeño, J. C., Fernández, O., Alvarez-Lafuente, R., Arroyo, R., & Castro, A. (2017). Metabolomic signatures associated with disease severity in multiple sclerosis. Neurology® Neuroimmunology & Neuroinflammation, 4(2), 1–10. https://doi.org/10.1212/NXI.0000000000000321
Chicago
Villoslada, Pablo, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, et al. 2017. “Metabolomic Signatures Associated with Disease Severity in Multiple Sclerosis.” Neurology® Neuroimmunology & Neuroinflammation 4 (2): 1–10. doi:10.1212/NXI.0000000000000321.